201 related articles for article (PubMed ID: 30306595)
21. A role for keratin 17 during DNA damage response and tumor initiation.
Nair RR; Hsu J; Jacob JT; Pineda CM; Hobbs RP; Coulombe PA
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33762306
[TBL] [Abstract][Full Text] [Related]
22. Expression of keratins (K10 and K17) in steatocystoma multiplex, eruptive vellus hair cysts, and epidermoid and trichilemmal cysts.
Tomková H; Fujimoto W; Arata J
Am J Dermatopathol; 1997 Jun; 19(3):250-3. PubMed ID: 9185910
[TBL] [Abstract][Full Text] [Related]
23. Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo.
Hobbs RP; Batazzi AS; Han MC; Coulombe PA
Oncogene; 2016 Oct; 35(43):5653-5662. PubMed ID: 27065324
[TBL] [Abstract][Full Text] [Related]
24. Keratin 17 regulates nuclear morphology and chromatin organization.
Jacob JT; Nair RR; Poll BG; Pineda CM; Hobbs RP; Matunis MJ; Coulombe PA
J Cell Sci; 2020 Oct; 133(20):. PubMed ID: 33008845
[TBL] [Abstract][Full Text] [Related]
25. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
[TBL] [Abstract][Full Text] [Related]
26. Keratin 17 expression in the hard epithelial context of the hair and nail, and its relevance for the pachyonychia congenita phenotype.
McGowan KM; Coulombe PA
J Invest Dermatol; 2000 Jun; 114(6):1101-7. PubMed ID: 10844551
[TBL] [Abstract][Full Text] [Related]
27. Shikonin inhibits IFN-γ-induced K17 over-expression of HaCaT cells by interfering with STAT3 signaling.
Liu L; Wu Y; Cao K; Xu YY; Gao XH; Chen HD; Geng L
Int J Clin Exp Pathol; 2015; 8(8):9202-7. PubMed ID: 26464667
[TBL] [Abstract][Full Text] [Related]
28. Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma.
Ide M; Kato T; Ogata K; Mochiki E; Kuwano H; Oyama T
Ann Surg Oncol; 2012 Oct; 19(11):3506-14. PubMed ID: 22695933
[TBL] [Abstract][Full Text] [Related]
29. A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23.
Marasca C; Megna M; Donnarumma M; Fontanella G; Cinelli E; Fabbrocini G
Skin Appendage Disord; 2020 Sep; 6(5):309-311. PubMed ID: 33088817
[TBL] [Abstract][Full Text] [Related]
30. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2.
Smith FJ; Jonkman MF; van Goor H; Coleman CM; Covello SP; Uitto J; McLean WH
Hum Mol Genet; 1998 Jul; 7(7):1143-8. PubMed ID: 9618173
[TBL] [Abstract][Full Text] [Related]
31. Steatocystoma multiplex and oligosymptomatic pachyonychia congenita of the Jackson-Sertoli type.
Hohl D
Dermatology; 1997; 195(1):86-8. PubMed ID: 9267753
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel interaction between annexin A2 and keratin 17: evidence for reciprocal regulation.
Chung BM; Murray CI; Van Eyk JE; Coulombe PA
J Biol Chem; 2012 Mar; 287(10):7573-81. PubMed ID: 22235123
[TBL] [Abstract][Full Text] [Related]
33. Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex.
Smith FJ; Corden LD; Rugg EL; Ratnavel R; Leigh IM; Moss C; Tidman MJ; Hohl D; Huber M; Kunkeler L; Munro CS; Lane EB; McLean WH
J Invest Dermatol; 1997 Feb; 108(2):220-3. PubMed ID: 9008238
[TBL] [Abstract][Full Text] [Related]
34. Multifaceted role of keratins in epithelial cell differentiation and transformation.
Dmello C; Srivastava SS; Tiwari R; Chaudhari PR; Sawant S; Vaidya MM
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180046
[TBL] [Abstract][Full Text] [Related]
35. Emergence of keratin 17 vs. loss of keratin 13: their reciprocal immunohistochemical profiles in oral carcinoma in situ.
Mikami T; Cheng J; Maruyama S; Kobayashi T; Funayama A; Yamazaki M; Adeola HA; Wu L; Shingaki S; Saito C; Saku T
Oral Oncol; 2011 Jun; 47(6):497-503. PubMed ID: 21489858
[TBL] [Abstract][Full Text] [Related]
36. Keratin 17 Impacts Global Gene Expression and Controls G2/M Cell Cycle Transition in Ionizing Radiation-Induced Skin Damage.
Yue Z; Lin J; Lu X; Gao Q; Pan M; Zhang Y; Shen S; Zhu WG; Paus R
J Invest Dermatol; 2023 Dec; 143(12):2436-2446.e13. PubMed ID: 37414246
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of keratin 17 in oropharyngeal squamous cell carcinoma is associated with decreased survival.
Regenbogen E; Mo M; Romeiser J; Shroyer ALW; Escobar-Hoyos LF; Burke S; Shroyer KR
Head Neck; 2018 Aug; 40(8):1788-1798. PubMed ID: 29626364
[TBL] [Abstract][Full Text] [Related]
38. Increased importin 13 activity is associated with the pathogenesis of pterygium.
Xu K; Tao T; Jie J; Lu X; Li X; Mehmood MA; He H; Liu Z; Xiao X; Yang J; Ma JX; Li W; Zhou Y; Liu Z
Mol Vis; 2013; 19():604-13. PubMed ID: 23559854
[TBL] [Abstract][Full Text] [Related]
39. Familial pachyonychia congenita with steatocystoma multiplex and multiple abscesses of the scalp due to the p.Asn92Ser mutation in keratin 17.
Ofaiche J; Duchatelet S; Fraitag S; Nassif A; Nougué J; Hovnanian A
Br J Dermatol; 2014 Dec; 171(6):1565-7. PubMed ID: 24842198
[No Abstract] [Full Text] [Related]
40. Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration.
Mikami T; Maruyama S; Abé T; Kobayashi T; Yamazaki M; Funayama A; Shingaki S; Kobayashi T; Jun C; Saku T
Virchows Arch; 2015 May; 466(5):559-69. PubMed ID: 25736868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
